Stress is typically characterized as "acute" (lasting from minutes to hours) or "chronic" (lasting from days to months). These terms are of limited use as they are inconsistently used and only encompass one aspect of the stressor (duration). Short and long duration stress are generally thought to produce specific outcomes (e.g. acute stress enhances while chronic stress suppresses immune function). We propose that aspects of stress other than duration, such as frequency and intensity, are important in determining its outcome. We experimentally manipulated duration, frequency, and intensity of application of exogenous corticosterone, CORT, in Sceloporus undulatus (Eastern fence lizards) and measured the immune outcomes. Our findings reveal that immune outcomes of stress are not easily predicted from the average amount or duration of CORT elevation, but that intensity plays an important role. Although three of our treatments received the same average amount of CORT, they produced different effects on immune outcomes (hemagglutination). As predicted by the literature, short-duration exposure to low-dose CORT enhanced hemagglutination; however, short-duration exposure to high-dose CORT suppressed hemagglutination, suggesting that stressor intensity affects immune outcomes of stress. While both are traditionally termed "acute" based on duration, these treatments produced different immune outcomes. Long-duration ("chronic") exposure to CORT did not produce the expected suppression of hemagglutination. Frequency of CORT application did not alter immune outcomes at low intensities. These results highlight the need to quantify more than just the duration of a stressor if we are to understand and manage the ecological consequences of stress. Specifically, we should consider stressor frequency and intensity, as well as duration, for a more complete characterization and understanding of stress.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ygcen.2015.07.008 | DOI Listing |
Clin Cosmet Investig Dermatol
January 2025
Department of Dermatology, Candidate Branch of National Clinical Research Centre for Skin and Immune Diseases, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People's Republic of China.
Dystrophic epidermolysis bullosa (DEB) is a heterogeneous and rare genetic skin disease caused by mutations in the gene, which encodes Type VII collagen. The absence or dysfunction of Type VII collagen can cause the dense lower layer of the basal membrane zone of the skin to separate from the dermis, leading to blister formation and various complications. In different DEB subtypes, the severity of the phenotype is associated, to some extent, with the outcome of Type VII collagen caused by mutations in the gene, which may be reduced in expression, remarkably reduced, or completely absent.
View Article and Find Full Text PDFEClinicalMedicine
February 2025
Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.
Background: Randomized clinical trials (RCTs) are fundamental to evidence-based medicine, but their real-world impact on clinical practice often remains unmonitored. Leveraging large-scale real-world data can enable systematic monitoring of RCT effects. We aimed to develop a reproducible framework using real-world data to assess how major RCTs influence medical practice, using two pivotal surgical RCTs in gynaecologic oncology as an example-the LACC (Laparoscopic Approach to Cervical Cancer) and LION (Lymphadenectomy in Ovarian Neoplasms) trials.
View Article and Find Full Text PDFJ Inflamm Res
January 2025
Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, People's Republic of China.
Ovarian cancer (OC) remains one of the most lethal gynecological malignancies, largely due to its late-stage diagnosis and high recurrence rates. Chronic inflammation is a critical driver of OC progression, contributing to immune evasion, tumor growth, and metastasis. Inflammatory cytokines, including IL-6, TNF-α, and IL-8, as well as key signaling pathways such as nuclear factor kappa B (NF-kB) and signal transducer and activator of transcription 3 (STAT3), are upregulated in OC, promoting a tumor-promoting environment.
View Article and Find Full Text PDFFront Immunol
January 2025
Department of Breast and Thyroid Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Background: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer, characterized by frequent recurrence, metastasis, and poor survival outcomes despite chemotherapy-based treatments. This study aims to investigate the mechanisms by which Traditional Chinese Medicine (TCM) modulates the tumor immune microenvironment in TNBC, utilizing CiteSpace and bioinformatics analysis.
Methods: We employed CiteSpace to analyze treatment hotspots and key TCM formulations, followed by bioinformatics analysis to identify the main active components, targets, associated pathways, and their clinical implications in TNBC treatment.
Front Immunol
January 2025
Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Introduction: Glioma is the most common primary malignant brain tumor. Despite advances in surgical techniques and treatment regimens, the therapeutic effects of glioma remain unsatisfactory. Immunotherapy has brought new hope to glioma patients, but its therapeutic outcomes are limited by the immunosuppressive nature of the tumor microenvironment (TME).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!